A randomized, open label, comparative, prospective study evaluating efficacy, safety and compliance of rosuvastatin versus atorvastatin in overweight and obese dyslipidemic patients

Authors
Category Primary study
JournalJK Science
Year 2017
This article has no abstract
Epistemonikos ID: ead8dac8d7c1e63fc026cb10525d4645d9023990
First added on: Apr 29, 2026